New antibody for breast cancer therapy. Interview by Brigitte Schalhorn
Eiermann, W.
FortschrittederMedizin 116(18-19): 18
1998
ISSN/ISBN: 0015-8178 PMID: 9691532 Document Number: 495720
Document emailed within 1 workday
Related Documents
Hirsch, R. 2011: Elderly patients. Shackled, beaten, shamed (interview by Dr. med. Brigitte Moreano) MMWFortschrittederMedizin 153(26-28): 22Chakraborty, M.; Mukerjee, S.; Foon, K.A.; Köhler, H.; Ceriani, R.L.; Bhattacharya-Chatterjee, M. 1995: Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody Cancer Research 55(7): 1525-1530
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-2325
Hooning, M.J.; van Dongen, J.A.; Went, G. 1991: Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation Netherlands Journal of Surgery 43(4): 102-104
Thomsen, K. 1987: Changes in the therapy of operable breast cancer. Treatment of small breast cancer and preinvasive stages Fortschritte der Medizin 105(22): 425-428
Ohsumi, S.; Takashima, S.; Saeki, T.; Aogi, K. 2002: Breast-conserving therapy consisting of wide excision, axillary dissection, and radiotherapy for early-stage breast cancer: the experience of the National Shikoku Cancer Center Biomedicine and PharmacoTherapy 56(Suppl): 196s-200s
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Shands, M.E.; Lewis, F.M.; Zahlis, E.H. 2000: Mother and child interactions about the mother's breast cancer: an interview study Oncology Nursing Forum 27(1): 77-85
Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
Friedrich, M. 2000: Vitamin D and breast cancer: new approaches for hormonal therapy of breast cancer Clinical and Experimental Obstetrics and Gynecology 27(2): 77-82
Denardo, S.J.; O'Grady, L.F.; Richman, C.M.; Goldstein, D.S.; O'Donnell, R.T.; Denardo, D.A.; Kroger, L.A.; Lamborn, K.R.; Hellström, K.E.; Hellström, I.; Denardo, G.L. 1997: Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibody Anticancer Research 17(3b): 1745-1751
Heinzl, S. 2000: Trastuzumab. Monoclonal antibody for the treatment of breast cancer Medizinische Monatsschrift für Pharmazeuten 23(11): 350-352
Edynak, E.M.; Hirshaut, Y.; Bernhard, M.; Trempe, G. 1972: Fluorescent antibody studies of human breast cancer Journal of the National Cancer Institute 48(4): 1137-1143
Estes, N.C.; Morse, P.A.; Humphrey, L.J. 1974: Antibody studies of sera from patients with breast cancer Surgical Forum 25(0): 121-123
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Lüscher, N.J. 1992: Reconstructive measures in local recurrence after breast saving therapy of breast cancer Helvetica Chirurgica Acta 59(1): 181-187
Seewald, D.H.; Zoidl, J.P.; Track, C.; Putz, E.; Hammer, J. 1994: Quality assurance of interstitial irradiation in the breast-conserving therapy of breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 170(3): 147-150
Tangkaratt, S. 2004: Mammographic findings in breast cancer patients, who were treated with breast conserving therapy Journal of the Medical Association of Thailand 87(12): 1439-1443